European pharma’s growth prescription: pivot to US
The biggest threat for European pharmaceutical groups currently comes from the United States. President-elect Donald Trump ...
Scandasia.com8h
Novo Nordisk expands footprint in China with recruitment shift
Novo Nordisk shifts its recruitment focus to China, expanding operations to meet rising demand for Ozempic and Wegovy in the ...
Wall Street Journal1d
Novo Nordisk Says White House Obesity Plan Is Step in Right Direction
Novo Nordisk is encouraged by White House proposals that could support patients using weight-loss drugs, but cautioned that ...
Insider Monkey15d
Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S ...
manilatimes19d
Novo Nordisk A/S purchases B shares worth DKK 4,736 million from Novo Holdings A/S under the 2024 share repurchase programme
Bagsværd, Denmark, 8 November 2024 - Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK 4,736,088,225.00 from Novo Holdings A/S. The ...
manilatimes20d
Novo Nordisk Pharma (Thailand) Ltd. Clinches Triple Triumph at Asia Pacific Enterprise Awards 2023 Thailand
SINGAPORE - Media OutReach Newswire - 22 December 2023 - Novo Nordisk Pharma (Thailand) Ltd. has emerged triumphant by securing three prestigious accolades at the Asia Pacific Enterprise Awards (APEA) ...
bnnbloomberg21d
Novo Nordisk’s Wegovy Sales Increase Reassures Investors
(Bloomberg) -- Novo Nordisk A/S posted surging sales of its blockbuster weight-loss treatment Wegovy, reassuring investors after rival Eli Lilly & Co. reported disappointing sales of its obesity ...
Daily Mail21d
Ten Americans die and 100 are hospitalized after taking Ozempic-like drugs
Ozempic maker Novo Nordisk claims these off-brand versions of its drugs are made with little regulation or oversight which raises the risk that someone could fall ill after using them. Few details ...
Yahoo21d
Wegovy sales are slaying for Novo Nordisk right now
Sales of Novo Nordisk’s (NVO) blockbuster weight loss drug Wegovy continue to soar, surpassing Wall Street expectations. The Danish pharma giant posted its third-quarter earnings report early ...
Investopedia21d
Novo Nordisk Stock Slips as Sales Grow Less Than Expected
James Manning / PA Images / Getty Images After rising in premarket trading, Novo Nordisk's U.S.-listed shares fell after the market opened Wednesday as its third-quarter sales fell short of ...
Investing22d
Novo Nordisk's Wegovy weight-loss drug sales beat forecast, shares jump
COPENHAGEN (Reuters) - Novo Nordisk (NYSE:NVO) reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug on Wednesday, reassuring investors worried that demand was ...
Morningstar22d
Novo Nordisk's Blockbuster Wegovy Sales Beat Expectations — Update
Novo Nordisk narrowed its full-year guidance after its blockbuster Wegovy weight-loss drug beat sales expectations in the third quarter. Soaring popularity for its obesity drug has seen demand far ...